Progressive disease rate as a surrogate endpoint of phase II trials for non-small-cell lung cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/4DCE288D.svg?ark=w1%2F20260515%2F4DCE288D)](https://nobleid.org/work/w1/20260515/4DCE288D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors